Braintree, Buyers Settle Generic MiraLax Suit For $17M

By Zach Winnick · January 20, 2012, 7:16 PM EST

Drug buyer plaintiffs in a putative antitrust class action accusing Braintree Laboratories Inc. of initiating baseless patent litigation to block a generic version of the laxative MiraLax asked a Delaware federal...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Rochester Drug Co-Operative Inc. v. Braintree Laboratories Inc.

Case Number

1:07-cv-00142

Court

Delaware

Nature of Suit

Anti-Trust

Date Filed

March 12, 2007